News & Press

    Insider Buying And A Spinoff Mean It’s Time To Take A Second Look At Arconic

    The serving Chairman and newly appointed CEO of the aluminum giant Arconic, which is facing a class action suit following the deaths of 72 victims in the London Grenfell fire in 2017, is cashing in and could make as much as $20 million in just a year as he takes a smoke-and-mirrors approach to the company’s future.

    Continue reading the full article…

    Why Debt, Scandal, And An Angry Trump Should Have AT&T Considering A Break-Up

    It’s got the scorch of a blistering Dallas plot: debt, politics, sex, and media-moguls-at-war, which all has the potential to spark a fresh break-up where shareholders are the ultimate winners.

    Continue reading the full article…

    The Death of Value Investing

    Value investing is dead – or so it seems to The Edge CEO Jim Osman, who caught up with Hedge Magazine in London for a discussion on this strategy’s future and his top ideas in the space.

    Continue reading the full article…

    21st Century Fox Takeover: Are Investors At Risk Of A No Deal Disney?

    John Steinbeck captured it best when he used the seminal Robert Burns poem ‘To a Mouse’ to lay the foundations for his own novella. But could the best-laid plans go awry when it comes to the most famous business deal on the planet?

    Continue reading the full article…

    Ferrari Spinoff Shares Spike As CEO Camilleri Buy Bolsters Bulls

    Ferrari’s CEO Louis C. Camilleri’s first purchase of stock has put him in the pole position to earn millions of dollars as the company goes from strength to strength. Last July, Ferrari announced Camilleri, former Chairman & CEO of Philip Morris International, was to take the helm following the stepping down of then-CEO & Chairman Sergio Marchionne.

    Continue reading the full article…

    The Edge CEO: Why Merck & Co should spin off its animal health division

    The Edge Consulting Group CEO Jim Osman tells Proactive Investors the investment research company that focuses on company spin-offs has compiled a report suggesting Merck & Co (NYSE: MRK) spin-off its animal health business, as the animal health business generates around $40 billion in revenue, The Edge expecting this to rise to $65 billion in 2025.

    Continue reading the full article…

    Why Following Activist Investors Can Make Your Cash Work For You In 2019

    Many investors will agree that 2018 was a wipe-out with algorithms causing chaos. As computers tried to find value, prompting never-before-seen swings, human investors were left counting the cost.

    Continue reading the full article…

    Activist Threat Seen Pushing Mega-Cap Laggards Into Spinoff Mode

    By Drew Singer / Bloomberg News:

    Continue reading the full article…

    Insider Supremo George Muzea Joins The Edge Amid Market Demand for Fresh Analysis

    Breaking up may not be hard to do if Amazon’s Jeff Bezos is to be believed, but when it comes to companies – the special situations market is growing arms and legs. Now, as money managers scramble for value, legend George Muzea is partnering with trendsetting firm The Edge following the success of their quarterly Spinoff conference in NYC.

    Continue reading the full article…

    Sports Betting, Advertising Spinoffs Pitched at Traders’ Huddle

    By Drew Singer / Bloomberg News:

    Continue reading the full article…